Cigna Corporation
CINYSEHealthcare● Active
$289.48
+$8.80(+3.14%)
Market Cap$76.6B
P/E Ratio—
52W High$338.89
52W Low$239.51
Cigna Corporation (CI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CI · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$7.79
Est. $7.60 · +2.5%
Revenue
$68.49B
Est. $66.29B · +3.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 5-Quarter EPS Beat Streak
CI reports quarterly as a NYSE-listed Medical - Healthcare Plans company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $7.58 | — | — | — | $70.21B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $7.60 | $7.79 | +2.5% | $68.49B | $66.29B | +3.3% |
| ▲ Q1 FY2026 | Feb 5, 2026 | $7.88 | $8.08 | +2.5% | $72.47B | $70.31B | +3.1% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $7.64 | $7.83 | +2.5% | $69.75B | $67.58B | +3.2% |
| — Q3 FY2025 | Jul 31, 2025 | $7.16 | $7.20 | +0.6% | $67.23B | $62.91B | +6.9% |
| ▲ Q2 FY2025 | May 2, 2025 | $6.35 | $6.74 | +6.1% | $65.50B | $60.20B | +8.8% |
| ▼ Q1 FY2025 | Jan 30, 2025 | $7.84 | $6.64 | -15.3% | $65.72B | $63.44B | +3.6% |
| ▲ Q4 FY2024 | Oct 31, 2024 | $7.23 | $7.51 | +3.9% | $62.77B | $59.47B | +5.5% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$7.58
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$7.79
EPS Est.
$7.60
EPS Surpr.
+2.5%
Revenue
$68.49B
Q1 FY2026
Feb 5, 2026Beat
EPS Actual
$8.08
EPS Est.
$7.88
EPS Surpr.
+2.5%
Revenue
$72.47B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$7.83
EPS Est.
$7.64
EPS Surpr.
+2.5%
Revenue
$69.75B
Q3 FY2025
Jul 31, 2025
EPS Actual
$7.20
EPS Est.
$7.16
EPS Surpr.
+0.6%
Revenue
$67.23B
Q2 FY2025
May 2, 2025Beat
EPS Actual
$6.74
EPS Est.
$6.35
EPS Surpr.
+6.1%
Revenue
$65.50B
Q1 FY2025
Jan 30, 2025Miss
EPS Actual
$6.64
EPS Est.
$7.84
EPS Surpr.
-15.3%
Revenue
$65.72B
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
$7.51
EPS Est.
$7.23
EPS Surpr.
+3.9%
Revenue
$62.77B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $8.85 | $9.33 | $9.72 | 9 |
| Q3 FY2028 | $8.75 | $9.22 | $9.60 | 7 |
| Q2 FY2028 | $8.58 | $9.04 | $9.42 | 6 |
| Q1 FY2028 | $8.68 | $9.15 | $9.54 | 6 |
| Q4 FY2027 | $8.01 | $8.44 | $8.79 | 5 |
| Q3 FY2027 | $8.06 | $8.49 | $8.85 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $78.7B | $81.9B | $84.6B | 3 |
| Q3 FY2028 | $76.0B | $79.1B | $81.7B | 5 |
| Q2 FY2028 | $74.5B | $77.5B | $80.0B | 3 |
| Q1 FY2028 | $72.3B | $75.3B | $77.7B | 3 |
| Q4 FY2027 | $74.6B | $77.7B | $80.2B | 4 |
| Q3 FY2027 | $72.2B | $75.2B | $77.6B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +2.5% | $292.32 | $290.58 | -0.60% |
| ▲ Q1 FY2026 | Feb 5, 2026 | +2.5% | $271.71 | $284.53 | +4.72% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +2.5% | $299.12 | $247.10 | -17.39% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +0.6% | $297.86 | $267.38 | -10.23% |
| ▲ Q2 FY2025 | May 2, 2025 | +6.1% | $335.18 | $334.75 | -0.13% |
| ▼ Q1 FY2025 | Jan 30, 2025 | -15.3% | $303.31 | $282.98 | -6.70% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +3.9% | $312.89 | $314.81 | +0.61% |
| ▲ Q3 FY2024 | Aug 1, 2024 | +4.8% | $348.67 | $332.60 | -4.61% |
Q2 FY2026-0.60%
Report Date
Apr 30, 2026
EPS Beat/Miss
+2.5%
Price Before
$292.32
Price After
$290.58
Q1 FY2026+4.72%
Report Date
Feb 5, 2026
EPS Beat/Miss
+2.5%
Price Before
$271.71
Price After
$284.53
Q4 FY2025-17.39%
Report Date
Oct 30, 2025
EPS Beat/Miss
+2.5%
Price Before
$299.12
Price After
$247.10
Q3 FY2025-10.23%
Report Date
Jul 31, 2025
EPS Beat/Miss
+0.6%
Price Before
$297.86
Price After
$267.38
Q2 FY2025-0.13%
Report Date
May 2, 2025
EPS Beat/Miss
+6.1%
Price Before
$335.18
Price After
$334.75
Q1 FY2025-6.70%
Report Date
Jan 30, 2025
EPS Beat/Miss
-15.3%
Price Before
$303.31
Price After
$282.98
Q4 FY2024+0.61%
Report Date
Oct 31, 2024
EPS Beat/Miss
+3.9%
Price Before
$312.89
Price After
$314.81
Q3 FY2024-4.61%
Report Date
Aug 1, 2024
EPS Beat/Miss
+4.8%
Price Before
$348.67
Price After
$332.60
Avg Beat Reaction-3.95%
Avg Miss Reaction-6.70%
Beat Rate7 / 8 quarters
Largest Move-17.39% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CI ends December
Cigna Corporation (CI) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $7.79 — beating the analyst consensus of $7.60 by +2.5%. CI has beaten EPS estimates for 5 consecutive quarters. The next CI earnings date is expected around September 1, 2026.
Each quarter, investors track CI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CI earnings · 5 questionsCigna Corporation's next earnings report is expected around September 1, 2026. CI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CI historically reports after market close (AMC).
CI earnings datewhen is CI earningsCI next earnings datewhen does CI report earningsCI earnings calendar
▸ Source: FMP · Cigna Corporation SEC filings · US GAAP · Cigna Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026